Patents by Inventor Robert G. Parsons

Robert G. Parsons has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7674623
    Abstract: The present invention relates to methods for making stable test samples that can be used in ligand-binding assays for measuring natriuretic peptides.
    Type: Grant
    Filed: November 5, 2007
    Date of Patent: March 9, 2010
    Assignee: Abbott Laboratories, Inc.
    Inventors: Robert G. Parsons, David J. Daghfal, Cherie A. Lipowsky, Ray A. Weigand, Judith A. Friese
  • Publication number: 20080248579
    Abstract: The present invention relates to methods for making stable test samples that can be used in ligand-binding assays for measuring natriuretic peptides.
    Type: Application
    Filed: November 5, 2007
    Publication date: October 9, 2008
    Applicant: ABBOTT LABORATORIES
    Inventors: Robert G. Parsons, David J. Daghfal, Cherie A. Lipowsky, Ray A. Weigand, Judith A. Friese
  • Patent number: 7291501
    Abstract: The present invention relates to methods for making stable compositions, such as, but not limited to, test samples, that can be used in ligand-binding assays.
    Type: Grant
    Filed: November 24, 2003
    Date of Patent: November 6, 2007
    Assignee: Abbott Laboratories
    Inventors: Robert G. Parsons, David J. Daghfal, Cherie A. Lipowsky, Ray A. Weigand, Judith A. Friese
  • Patent number: 5518887
    Abstract: The present invention relates to immunoassay methods for detecting and measuring the amount of an analyte in a sample by means of generic anti-hapten antibodies. Also disclosed are multi-analyte immunoassay methods. Reagents, devices, and kits using the anti-hapten antibodies are also disclosed. The present invention also relates to immunoassay methods for detecting and measuring the amount of an analyte in a sample by means of a dual antibody format.The present invention also relates to dyed erythrocytes, preferably fixed, which are coated with antibodies. Also disclosed is the use of these dyed erythrocytes in agglutination assays to detect and measure the presence of an analyte in a sample. The analyte can be a hapten, an antigen, or an antibody. Also included are agglutination assays, compositions and kits using these dyed and coated erythrocytes.
    Type: Grant
    Filed: December 1, 1993
    Date of Patent: May 21, 1996
    Assignee: Abbott Laboratories
    Inventors: Robert G. Parsons, Robert Kowal
  • Patent number: 5248479
    Abstract: A device for performing agglutination immunoassay reactions and the like is disclosed. The device includes a first hydrophilic layer, a second liquid-occlusive layer parallel to and overlying the first layer, and a third layer parallel to and overlying the second layer. The third layer has a transparent opening for observing particles. The second layer is interposed between and in adherent relationship to the first and third layers. The second layer has at least one slot defining a channel for directing liquid conducted by capillary action through the chamber defined in conjunction with the first and third layers. This chamber has a proximate zone and a distal zone. The geometry of the chamber is modified to provide preferably outwardly diverging walls and provide a flowpath having different rates of flow per unit area along the paths.
    Type: Grant
    Filed: December 22, 1992
    Date of Patent: September 28, 1993
    Assignee: Abbott Laboratories
    Inventors: Robert G. Parsons, Bob O. Basore, Michael B. O'Connell, Kevin J. Forney, Paul J. Ropella, Andrew J. Muetterties
  • Patent number: 5209904
    Abstract: An improved device for performing agglutination reactions is disclosed. The device has at least one chamber with a proximate zone and a distal zone in which chamber agglutination reactions can be performed. The improvement comprises utilization in the device of a layer of liquid absorbent material for controlling overall rate of liquid flow through the chamber. The layer of liquid absorbent material is selectively impregnated with a substance to form an impregnated region and a non-impregnated region wherein the non-impregnated region is liquid absorbent and the impregnated region is liquid-occlusive. A portion of the non-impregnated region is positioned within the distal zone of the chamber so that the non-impregnated region is in liquid communication with that zone.
    Type: Grant
    Filed: November 16, 1990
    Date of Patent: May 11, 1993
    Assignee: Abbott Laboratories
    Inventors: Kevin J. Forney, Robert G. Parsons, Paul J. Ropella, Bob O. Basore, Michael B. O'Connell